First‐line cetuximab+ platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE

C Le Tourneau, M Ghiani, MC Cau, R Depenni… - Cancer …, 2023 - Wiley Online Library
Background ENCORE, an observational, prospective, open‐label study, investigated real‐
world treatment practices and outcomes with cetuximab plus platinum‐based therapy (PBT) …
相关文章
[PDF] researchgate.net

[PDF][PDF] First-line cetuximab+ platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study—ENCORE

C Le Tourneau, M Ghiani, MC Cau, R Depenni… - 2023 - researchgate.net
Background: ENCORE, an observational, prospective, open-label study, investigated real-
world treatment practices and outcomes with cetuximab plus platinum-based therapy (PBT) …

First‐line cetuximab+ platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE.

C Le Tourneau, M Ghiani, MC Cau, R Depenni… - Cancer …, 2023 - go.gale.com
Background: ENCORE, an observational, prospective, open‐label study, investigated real‐
world treatment practices and outcomes with cetuximab plus platinum‐based therapy (PBT) …
[HTML] nih.gov

[HTML][HTML] First‐line cetuximab+ platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE

C Le Tourneau, M Ghiani, MC Cau, R Depenni… - Cancer …, 2023 - ncbi.nlm.nih.gov
Background ENCORE, an observational, prospective, open‐label study, investigated real‐
world treatment practices and outcomes with cetuximab plus platinum‐based therapy (PBT) …

First-line cetuximab+ platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE

C Le Tourneau, M Ghiani, MC Cau… - Cancer reports …, 2023 - pubmed.ncbi.nlm.nih.gov
Background ENCORE, an observational, prospective, open-label study, investigated real-
world treatment practices and outcomes with cetuximab plus platinum-based therapy (PBT) …

First-line cetuximab+ platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.

C Le Tourneau, M Ghiani, MC Cau… - Cancer Reports …, 2023 - europepmc.org
Background ENCORE, an observational, prospective, open-label study, investigated real-
world treatment practices and outcomes with cetuximab plus platinum-based therapy (PBT) …

First-line cetuximab+ platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.

C Le Tourneau, M Ghiani, MC Cau… - Cancer Reports …, 2023 - europepmc.org
Background ENCORE, an observational, prospective, open-label study, investigated real-
world treatment practices and outcomes with cetuximab plus platinum-based therapy (PBT) …